"Future investigations are warranted to disentangle the relative contribution of antipsychotic medications, maternal mental illness, concomitant (associated) medications and the broader psychosocial context in the developmental trajectory of high-risk infants. Pending such studies, these data support an additional level of clinical scrutiny in medication selection, treatment planning and risk/benefit discussions for women with illnesses who may warrant antipsychotic pharmacotherapy during gestation." http://www.medicalnewstoday.com/articles/243798.php Powered by LSoft's LISTSERV(R) list management software